Read more on recent MTX adherence publication … Read More
Author Archives: aardexwp
Important milestone in managing adherence to anti-osteoporosis treatment
AARDEX’s scientific lead Bernard Vrijens is a co-author of the new publication in the Osteoporosis International journal about determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment. … Read More
This video shows how to speed up your drug development.
Discover why the Pharmaceutical world trusts us to resolve patient non-compliance. … Read More
AARDEX Group is invited as a guest speaker at the 2019 European Respiratory Society (ERS)
Bernard Vrijens, CEO of AARDEX Group, is invited as a guest speaker at the 2019 annual meeting of the ERS, Madrid, Spain, September 30, 2019. … Read More
A Six Sigma framework to successfully manage medication adherence
Discover our CEO’s last publication in the British Journal of Clinical Pharmacology … Read More
AARDEX Group will be at BIO International Convention (3-6 June, 2019)
AARDEX Group, the leader in medication adherence monitoring and management … Read More
AARDEX Group is invited as a guest speaker at the 2019 ASCPT
Bernard Vrijens, CEO of AARDEX Group, is invited as a guest speaker at the 2019 … Read More
AARDEX leading position in the B2B medication adherence market
AARDEX still confirms its leading position in the B2B medication adherence market … Read More
AARDEX solutions facilitate the NARC Non-adherence classification in clinical trials
DEC-2018 : Electronic compilation of drug dosing history data using MEMS® … Read More
AARDEX embraces EMERGE for consistent and accurate reporting of medication adherence
DEC-2018 : Under the auspices of ESPACOMP, an international panel of experts recently … Read More